RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
  • Brazil: New Agreement Paves Way for Manufacturing Facilities to Produce Multiple Drug Types

    Based on a 7 May agreement between Brazil's National Health Surveillance Agency (ANVISA) and the Ministry of Agriculture, Livestock and Supply (MAPA), companies will be allowed to produce drugs for both veterinary and human use in the same manufacturing facility as long as the active ingredients and excipients have been approved for both human and veterinary use. Companies wishing to take advantage of this new approach will be required to obtain Certificates of Good Ma...